TITLE

Hematology

PUB. DATE
August 1997
SOURCE
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS29
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents an abstract of the research manuscript `Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep-vein thrombosis,' by K. Valentine, G. Raskob et al from the University of Calgary. Activated partial thromboplastin time (APTT).
ACCESSION #
9708236087

 

Related Articles

  • Hematology.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS29 

    Presents an abstract of the research manuscript `The relationship between initial heparin therapy and recurrent venous thromboembolism in patients with venous thrombosis,' by K.A. Valentine, R.D. Hull from the University of Oklahoma.

  • Hematology.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS32 

    Presents an abstract of the research manuscript `Cost effectiveness of outpatient LMWH compared to inpatient standard heparin in deep vein thrombosis (DVT) treatment,' by M. Rodger, C. Bredeson et al from the University of Ottawa. Low molecular weight heparin (LMWH).

  • Subcutaneous calcium heparin versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective randomised trial. Walker, M.G.; Shaw, J.W.; Thomson, G.J.L.; Cumming, J.G.R.; Thomas, M. Lea // British Medical Journal (Clinical Research Edition);5/9/1987, Vol. 294 Issue 6581, p1189 

    Compares the efficacy between subcutaneous calcium heparin and intravenous sodium heparin on the treatment of patients with established acute deep vein thrombosis in the legs. Difference on the reaction of patients between the two treatments; Complications of the treatment; Advantages of the...

  • Multicenter study on hemorrhagic risk of heparin bridging therapy for periendoscopic thromboprophylaxis. Mio Matsumoto; Katsuhiro Mabe; Momoko Tsuda; Masayoshi Ono; Saori Omori; Masakazu Takahashi; Takeshi Yoshida; Shoko Ono; Manabu Nakagawa; Soichi Nakagawa; Yuichi Shimizu; Takahiko Kudo; Naoya Sakamoto; Mototsugu Kato // BMC Gastroenterology;Jul2015, Vol. 15 Issue 1, p1 

    Background: For endoscopic interventions, heparin bridging therapy is recommended in patients who are at high risk from interruption of antithrombotic therapy. Although heparin bridging has been reported to be effective in preventing thrombosis, several reports have raised concerns about...

  • Potential savings through drugs?  // CMAJ: Canadian Medical Association Journal;11/01/97, Vol. 157 Issue 9, p1194 

    Relates a report from the `DUE Quarterly' newsletter, a joint effort of the Alberta Medical Association and the Alberta Pharmaceutical Association. Low-molecular-weight heparin therapy for the treatment of proximal vein thrombosis in elderly patients; Potential budgetary savings in the hospital...

  • Acting quickly in DVT.  // Patient Care;3/15/1998, Vol. 32 Issue 5, p169 

    Looks at activated partial thromboplastin time (APTT) into the therapeutic range, which is brought about due to the use of heparin therapy in deep vein thrombosis (DVT) patients. Detailed information on APTT and DVT patients.

  • Low-molecular-weight heparin may reduce hospital stays.  // Mayo Clinic Health Letter;Dec1996, Vol. 14 Issue 12, p4 

    Reports on the use of low-molecular-weight heparin for deep-vein thrombosis (DVT). Description of DVT; Nonrequirement of intense monitoring of therapy.

  • Enoxaparin lowers risk of DVT after total hip replacement.  // Geriatrics;Nov96, Vol. 51 Issue 11, p64 

    Presents an abstract of the article `Risk of Deep-Venous Thrombosis After Hospital Discharge in Patients Having Undergone Total Hip Replacement: Double-Blind, Randomised Comparison of Enoxaparin Versus Placebo,' by A. Planes, N. Vochelle, et al, published in the 1996 edition of the `Lancet'...

  • Heparin may not be so safe for lower GI bleed patients.  // Reactions Weekly;1/8/2011, Issue 1333, p5 

    This article reports on a study on the safety of using heparin for deep vein thrombosis prophylaxis and its link with the risk of continued bleeding in patients with a lower gastrointestinal bleed, which was presented at the 76th Annual Meeting of the American College of Chest Physicians.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics